Top Clinical Research Stories


Comment & Analysis »

GlobalData Healthcare

Still hope for Lirilumab-Opdivo combination despite disappointing monotherapy data

On February 6, Innate Pharma announced that the randomized, placebo-controlled, Phase II EffiKIR trial (NCT01687387) evaluating lirilumab as a single-agent maintenance treatment in elderly...

Still hope for Lirilumab-Opdivo combination despite disappointing monotherapy data
GlobalData Healthcare

Persistence may be Novavax’s greatest asset in its quest to develop an RSV vaccine

Persistence may be Novavax’s greatest asset in its quest to develop an RSV vaccine
GlobalData Healthcare

The importance of real world evidence in the 21st Century Cures Act

The importance of real world evidence in the 21st Century Cures Act
GlobalData Healthcare

Positive Phase IIb results position Synthetic Biologics’ Ribaxamase as serious contender for C. difficile Prophylaxis

Positive Phase IIb results position Synthetic Biologics’ Ribaxamase as serious contender for C. difficile Prophylaxis
GlobalData Healthcare

ImmunoGen is poised to solve a major unmet medical need in ovarian cancer

ImmunoGen is poised to solve a major unmet medical need in ovarian cancer

Company Releases »

ePAT Automated Lab Reactor Optimised for 24/7 Data Capture

SYSTAG Systems Technik
ePAT Automated Lab Reactor Optimised for 24/7 Data Capture

How Investing in Malvern Instruments Helped KBI Biopharma Find a Clear Commercial Advantage

Malvern Instruments
How Investing in Malvern Instruments Helped KBI Biopharma Find a Clear Commercial Advantage

Optimising Development Resources for Efficient Product Development

SYSTAG Systems Technik Optimising Development Resources for Efficient Product Development

GPC/SEC Analysis of Polymer Solutions Used in Inkjet Printing

Malvern Instruments
GPC/SEC Analysis of Polymer Solutions Used in Inkjet Printing

Gold Nanoparticle Applications and Characterization by Nanoparticle Tracking Analysis

Malvern Instruments Gold Nanoparticle Applications and Characterization by Nanoparticle Tracking Analysis

Clinical Research Insights »

Companies »